[
    [
        {
            "time": "2020-10-08",
            "original_text": "陆金所控股提交纽交所上市申请；吉利汽车9月总销量同比升11%至12.6万部",
            "features": {
                "keywords": [
                    "陆金所控股",
                    "纽交所",
                    "上市申请",
                    "吉利汽车",
                    "销量"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融",
                    "汽车"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "陆金所控股提交纽交所上市申请；吉利汽车9月总销量同比升11%至12.6万部",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-10-09",
            "original_text": "晚间公告热点追踪：7.3万股东难眠 240亿市值啤酒股董事长被调查",
            "features": {
                "keywords": [
                    "啤酒股",
                    "董事长",
                    "调查"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "食品饮料"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "晚间公告热点追踪：7.3万股东难眠 240亿市值啤酒股董事长被调查",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 8,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-10-08",
            "original_text": "公告精选：陆金所控股提交境外上市申请；宁波华翔拟实施欧洲业务重组",
            "features": {
                "keywords": [
                    "陆金所控股",
                    "上市申请",
                    "宁波华翔",
                    "欧洲业务重组"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融",
                    "汽车零部件"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "公告精选：陆金所控股提交境外上市申请；宁波华翔拟实施欧洲业务重组",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 6,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-10-08",
            "original_text": "燕京啤酒董事长被立案调查；复星医药：用于治疗新冠肺炎的药物获批",
            "features": {
                "keywords": [
                    "燕京啤酒",
                    "董事长",
                    "调查",
                    "复星医药",
                    "新冠药物",
                    "获批"
                ],
                "sentiment_score": 0.2,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "食品饮料",
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "燕京啤酒董事长被立案调查；复星医药：用于治疗新冠肺炎的药物获批",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-10-09",
            "original_text": "复星医药控股子公司用于治疗新冠的HLX70获美国FDA药品临床试验批准",
            "features": {
                "keywords": [
                    "复星医药",
                    "HLX70",
                    "新冠",
                    "FDA",
                    "临床试验"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "复星医药控股子公司用于治疗新冠的HLX70获美国FDA药品临床试验批准",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 10
            }
        },
        {
            "time": "2020-10-09",
            "original_text": "医药生物行业周观点：医药板块迎来配置时点，关注行业三季报，维持“强于大市”评级",
            "features": {
                "keywords": [
                    "医药生物",
                    "配置时点",
                    "三季报",
                    "强于大市"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药生物行业周观点：医药板块迎来配置时点，关注行业三季报，维持“强于大市”评级",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 8,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        }
    ]
]